Suscribirse

Wearable electrocardiogram devices in patients with congenital long QT syndrome: The SMART-QT study - 01/06/24

Doi : 10.1016/j.acvd.2024.02.010 
Antoine Delinière a, b, c, d, 1, Francis Bessière b, e, f, Leslie Placide g, Jean-Luc Pasquié g, h, Christelle Haddad b, Solenn Tirel a, Hajira Mokhtar a, Elodie Morel a, Kevin Gardey b, Arnaud Dulac b, Geoffroy Ditac b, Frédéric Sacher d, i, j, Isabelle Denjoy d, k, Philippe Chevalier a, b, c, d,
a National Reference Centre for Inherited Arrhythmia of Lyon (CERA), Hôpital Cardiologique Louis Pradel, Hospices Civils de Lyon, 69500 Bron, France 
b Electrophysiology Unit, Hôpital Cardiologique Louis Pradel, Hospices Civils de Lyon, 69500 Bron, France 
c Université Claude-Bernard Lyon-1, MeLiS, CNRS UMR 5284, INSERM U1314, Institut NeuroMyoGène, 69008 Lyon, France 
d European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARD-Heart) 
e Paediatric and Congenital Heart Disease Medico-Surgical Unit, Hôpital Cardiologique Louis Pradel, Hospices Civils de Lyon, 69500 Bron, France 
f Université Claude-Bernard Lyon-1, LabTau, Inserm, 69003 Lyon, France 
g Service de Cardiologie, Centre de Compétence des Troubles du Rythme Cardiaque d’Origine Héréditaire, Hôpital Arnaud-de-Villeneuve, CHU de Montpellier, 34295 Montpellier, France 
h CNRS UMR9214, Inserm U1046, PHYMEDEXP, Université de Montpellier, 34295 Montpellier, France 
i Institut LIRYC, Centre de référence des MAladies RYthmiques héréditaire (CMARY), Bordeaux University Hospital, 33000 Bordeaux, France 
j Université de Bordeaux, Inserm, CRCTB, U1045, 33000 Bordeaux, France 
k Service de Cardiologie, Centre de Référence des Troubles du Rythme Cardiaque d’Origine Héréditaire, Hôpital Bichat-Claude-Bernard, AP–HP, 75018 Paris, France 

Corresponding author. Electrophysiology Unit, Louis-Pradel Hospital, 26, avenue du Doyen-Jean-Lépine, 69500 Bron, France.Electrophysiology Unit, Louis-Pradel Hospital26, avenue du Doyen-Jean-LépineBron69500France

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Graphical abstract




El texto completo de este artículo está disponible en PDF.

Highlights

Two wearable ECG devices were evaluated in patients with congenital LQTS.
The various genotypes and ST-T wave patterns seen in this disease were represented.
The QTc and ST-T wave patterns obtained with these devices were correlated with the ECG.

El texto completo de este artículo está disponible en PDF.

Abstract

Background

In patients with congenital long QT syndrome (LQTS), the risk of ventricular arrhythmia is correlated with the duration of the corrected QT interval and the changes in the ST-T wave pattern on the 12-lead surface electrocardiogram (12L-ECG). Remote monitoring of these variables could be useful.

Aim

To evaluate the abilities of two wearable electrocardiogram devices (Apple Watch and KardiaMobile 6L) to provide reliable electrocardiograms in terms of corrected QT interval and ST-T wave patterns in patients with LQTS.

Methods

In a prospective multicentre study (ClinicalTrials.gov identifier: NCT04728100), a 12L-ECG, a 6-lead KardiaMobile 6L electrocardiogram and two single-lead Apple Watch electrocardiograms were recorded in patients with LQTS. The corrected QT interval and ST-T wave patterns were evaluated manually.

Results

Overall, 98 patients with LQTS were included; 12.2% were children and 92.8% had a pathogenic variant in an LQTS gene. The main genotypes were LQTS type 1 (40.8%), LQTS type 2 (36.7%) and LQTS type 3 (7.1%); rarer genotypes were also represented. When comparing the ST-T wave patterns obtained with the 12L-ECG, the level of agreement was moderate with the Apple Watch (k=0.593) and substantial with the KardiaMobile 6L (k=0.651). Regarding the corrected QT interval, the correlation with 12L-ECG was strong for the Apple Watch (r=0.703 in lead II) and moderate for the KardiaMobile 6L (r=0.593). There was a slight overestimation of corrected QT interval with the Apple Watch and a subtle underestimation with the KardiaMobile 6L.

Conclusions

In patients with LQTS, the corrected QT interval and ST-T wave patterns obtained with the Apple Watch and the KardiaMobile 6L correlated with the 12L-ECG. Although wearable electrocardiogram devices cannot replace the 12L-ECG for the follow-up of these patients, they could be interesting additional monitoring tools.

El texto completo de este artículo está disponible en PDF.

Keywords : Long QT syndrome, QT interval, Remote monitoring, Smartwatch, Digital health


Esquema


 Tweet: Wearable ECG devices in patients with congenital long QT syndrome (LQTS): a French multicenter study (SMART-QT study).


© 2024  Publicado por Elsevier Masson SAS.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 117 - N° 5

P. 313-320 - mai 2024 Regresar al número
Artículo precedente Artículo precedente
  • Atrioventricular conduction disorders in aortic valve infective endocarditis
  • Mary Philip, Jérôme Hourdain, Noémie Resseguier, Frédérique Gouriet, Jean-Paul Casalta, Florent Arregle, Sandrine Hubert, Alberto Riberi, Jean-Philippe Mouret, Vartan Mardigyan, Jean-Claude Deharo, Gilbert Habib
| Artículo siguiente Artículo siguiente
  • Aortic valve replacement for aortic stenosis: Influence of centre volume on TAVR adoption rates and outcomes in France
  • Nadav Willner, Virginia Nguyen, Graeme Prosperi-Porta, Helene Eltchaninoff, Ian G. Burwash, Morgane Michel, Eric Durand, Martine Gilard, Christel Dindorf, Julien Dreyfus, Bernard Iung, Alain Cribier, Alec Vahanian, Karine Chevreul, David Messika-Zeitoun

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.